Key Insights

Highlights

Treatment Research

2 treatments under study, led by Aspirin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04718025Phase 3Unknown

Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

Showing all 1 trials

Research Network

Common Treatments

  • Aspirin1
  • Ticagrelor1

Active Sponsors

  • Medical Research Agency, Poland1
  • Collegium Medicum w Bydgoszczy1
  • Nicolaus Copernicus University1

Top Investigators

Related Conditions

  • Unstable Angina1
  • Stemi1
  • Nstemi1

Activity Timeline